BIIB

Biogen, Inc. (NASDAQ: BIIB) Q4 2021 earnings call dated Feb. 03, 2022 Corporate Participants: Michael Hencke — Head of Investor Relations Michel…

Neurological and neurodegenerative diseases affect a vast segment of the population worldwide and there is a significant demand for treatments…

Biogen Inc (NASDAQ: BIIB) Q3 2021 Earnings Conference

Biogen, Inc.  (NASDAQ: BIIB) Q3 2021 earnings call dated Oct. 20, 2021 Corporate Participants: Michael Hencke — Investor Relations Michel Vounatsos — Chief Executive…

Biogen Inc. (NASDAQ: BIIB) Q2 2021 earnings call dated Jul. 22, 2021 Corporate Participants: Mike Hencke — Director of Investor Relations Michel…

Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Thursday said its second-quarter earnings and revenues decreased from last year. The results, however,…

Biogen Inc (NASDAQ: BIIB) Q2 2021 Earnings Conference

The pharmaceutical industry has been witnessing hectic activity for some time, with most drug makers either channelizing their resources for…

Biogen Inc. (NASDAQ: BIIB) Q1 2021 earnings call dated Apr. 22, 2021 Corporate Participants: Mike Hencke — Director of Investor Relations Michel…

Biogen Inc. (NASDAQ: BIIB) reported first quarter 2021 earnings results today. Total revenues decreased 24% year-over-year to $2.6 billion. On…